[1]
2026. Blood Tumor Mutational Burden as a Predictive Biomarker in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Pakistan Journal of Medical & Cardiological Review. 5, 2 (May 2026), 2361–2369. DOI:https://doi.org/10.66021/pakmcr1041.